Cyclin D3 anticorps (pSer283)

N° du produit ABIN1531266

Cet anticorps Lapin Polyclonal détecte spécifiquement Cyclin D3 dans WB, ELISA et IHC. Il présente une réactivité envers Humain, Souris et Rat.

Aperçu rapide pour Cyclin D3 anticorps (pSer283) (ABIN1531266)

Antigène: Cyclin D3 (CCND3)

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Cyclin D3 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Détail du produit anti-Cyclin D3 anticorps

Épitope: AA 243-292, pSer283

Specificité:

Cyclin D3 (Phospho-Thr283) Antibody detects endogenous levels of Cyclin D3 only when phosphorylated at Thr283.

PhosphorylationH:S283 M:S283 R:S284

Purification: The antibody was purified from rabbit antiserum by affinity-chromatography using phospho peptide. The antibody against non-phospho peptide was removed by chromatography using corresponding non-phospho peptide.

Pureté: > 95 %

Immunogène: The antiserum was produced against synthesized peptide derived from human Cyclin D3 around the phosphorylation site of Thr283.

Isotype: IgG

Information d'application

Indications d'application: WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:1000

Commentaires:

Unigene-Number: Hs.534307 (NCBI Gene Symbol: CCND3)

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Stable at -20°C for at least 1 year.

Date de péremption: 12 months

Détails sur Cyclin D3

Antigène: Cyclin D3 (CCND3)

Autre désignation: Cyclin D3

Sujet:

Synonyms: CCND3, CGD3, Cyl-3, G1/S-specific cyclin D3

NCBI Gene Symbol: CCND3

Poids moléculaire: 32 kDa

ID gène: 896

OMIM: 123834

UniProt: P30281

Pathways: Cycle Cellulaire, Mitotic G1-G1/S Phases, Glycosaminoglycan Metabolic Process